Adam Kaplin

Adam Kaplin

No más puestos en curso
59 años
Consumer Services
Health Technology
Health Services

Perfil

Adam Kaplin was the founder of MIRA Pharmaceuticals, Inc., founded in 2020, where the title held was President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also the founder of Nousynapse Pharmaceuticals..
Dr. Kaplin is currently the Director-Johns Hopkins Ketamine Clinic at The Johns Hopkins University since 2002.
Dr. Kaplin is also currently the Director at Cody Unser First Step Foundation since 2005.
Formerly, Dr. Kaplin was Chief Scientific Officer at Q from 2020 to 2024.
Education includes a doctorate from The Johns Hopkins University conferred in 1996 and an undergraduate degree from Yale University conferred in 1988.

Cargos activos de Adam Kaplin

EmpresasCargoInicio
Corporate Officer/Principal 01/01/2002
Director/Miembro de la Junta 01/01/2005

Antiguos cargos conocidos de Adam Kaplin.

EmpresasCargoFin
Q/C TECHNOLOGIES, INC. Director Técnico/Científico/I+D 15/04/2024
MIRA PHARMACEUTICALS, INC. Fundador 07/03/2024
Ver el detalle de la experiencia de Adam Kaplin.

Formación de Adam Kaplin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

95

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas5

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology